Uploads
Contact
/
Login
Upload
Search Results for 'Guidance Health'
Issue Date: February 2009
yoshiko-marsland
Guidance for Indu stry ions xed ling for Human Prescri
giovanna-bartolotta
Guidance for Industry Submitting and Reviewing Complete Responses to Clinical Ho
min-jolicoeur
Guidance for Clinical Investigators Sponsors and IRBs Investigational New Drug A
natalia-silvester
Types of Guidance
yoshiko-marsland
The regulator’s View:
karlyn-bohler
Hitting a moving target
alexa-scheidler
SBTAF
luanne-stotts
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product DRAFT
mitsue-stanley
Guidance for Industry Adverse Reactions Section of Labeling for Huma
alexa-scheidler
www.defra.gov.uk
ellena-manuel
GUIDANCE ON FAMILY REUNIFICATION
pamella-moone
DRAFT GUIDANCE This guidance document is being di stributed for comment p
ellena-manuel
Guidance on Electioneering Activities
giovanna-bartolotta
Seafish Guidance on Proce
celsa-spraggs
Guidance Notes for Law Enforcement Officers PubBar Cra
lindy-dunigan
You will find guidance
olivia-moreira
Guidance for Industry Oversight of Clinical Investigations A RiskBased Approach to Monitoring
luanne-stotts
Workplace (Health, Safety and Welfare) Regulations 1992require floors
briana-ranney
Guidance for Industry Oversight of Clinical Investigations A RiskBased Approach to Monitoring
ellena-manuel
Health and Safety Executive of pages Guidance for Employers on the Control of
faustina-dinatale
Guidance for Industry Clinical Data Needed to Support the Licensure of Seasonal
marina-yarberry
Guidance for Industry Size of Beads in Drug Products Labeled for Sprinkle U
myesha-ticknor
Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER Regulated
faustina-dinatale
1
2
3
4
5
6
7
8
9
10